optima chemical supply semaglutide Anti-obesity Medications and Muscle Loss A small study presented at ENDO 2025 suggested taking the anti-obesity medication can raise the risk of muscle loss. Researcher Melanie Haines, MD, discussed the findings Semaglutide Weight Loss in Miami

(28) The crude incidence rates of LLA were 6.1 per 10,000 person-years for GLP-1 receptor agonists, 1.5 for SGLT-2 inhibitors, 4.6 for DPP-4 inhibitors, and 1.9 for older agents

5) History of pancreatitis (in some cases)

the Diabetes Control and Complications Trial-Epidemiology of Diabetes Interventions and Complications analysis reported a prevalence of 47%

Remember: an accurate diagnosis of DKA or HK-CHS means youll get the proper treatment

In rodent studies, GLP-1 medications caused thyroid C-cell tumors, including medullary thyroid carcinoma (MTC)

REDEFINE 1 and REDEFINE 2 are completed phase 3 trials published in NEJM with over 4,600 participants